Google DeepMind Releases AlphaGenome 2 for Cell-Type-Specific Variant Effects

MarkTechPost
Read full story· 5 min
Google DeepMind launched AlphaGenome 2, a DNA model predicting variant effects in specific cell types using a 1 Mb DNA input and cell-state conditioning. It outperforms its predecessor and adapts to unseen single-cell data without fine-tuning, accessible via API for non-commercial research.

More in Healthcare